Nobel Resources Corp. Closes Final Tranche of LIFE Offering and Reports Annual Meeting Results
Overview
Nobel Resources Corp. announced it has closed the second and final tranche of its previously announced private placement of units under the listed issuer financing exemption (the LIFE Offering). The Company issued 4,250,000 units at $0.05 per unit for gross proceeds of $212,500, and the LIFE Offering closed on a fully-subscribed basis with total gross proceeds of $2,500,000. Net proceeds are intended to fund continued exploration work on Nobel’s Chilean mineral properties and for general corporate and working capital purposes.
Key Highlights
- Closed the second and final tranche of the LIFE Offering: 4,250,000 units issued at $0.05 per unit for gross proceeds of $212,500.
- LIFE Offering fully subscribed in aggregate: 50,000,000 units issued for total gross proceeds of $2,500,000.
- Each unit consists of 1 common share and 1/2 common share purchase warrant; each whole warrant is exercisable at $0.06 for 24 months from the date of the release and is not exercisable until 70 days after today’s date.
- Offering led by iA Private Wealth Inc. as lead agent and bookrunner, with Velocity Trade Capital Ltd. and Haywood Securities Inc. as syndicate agents; agents received an aggregate cash fee of $14,875 and 297,500 broker warrants.
- At the annual and special meeting held December 16, 2025, shareholders elected the nominees listed in the management proxy circular dated October 31, 2025 as directors, approved the appointment of auditors, and approved the Company’s stock option plan.
Strategic & Operational Context
The Company stated the net proceeds of the LIFE Offering will be used to continue exploration work on its Chilean mineral properties and for general corporate and working capital purposes.
Resources / Financials
- Each broker warrant is exercisable to acquire 1 common share at an exercise price of $0.05 for 24 months from today’s date.
- Shares and warrants issued under the LIFE second tranche are not subject to a statutory hold period under applicable Canadian securities laws because the tranche was completed under Part 5A of National Instrument 45-106 - Prospectus Exemptions (as amended by Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption).
- The LIFE second tranche remains subject to final approval of the TSX Venture Exchange.
What to Watch Next
- Final approval of the LIFE second tranche by the TSX Venture Exchange.
- Warrant exercisability timing: warrants will not be exercisable until 70 days after today’s date.
Commentary
The final closing completes a fully subscribed $2.5 million listed issuer financing, providing gross proceeds earmarked for continued exploration activities in Chile and general corporate purposes. The disclosed warrant structure and agent compensation outline the key economic terms associated with the financing.
About Nobel Resources Corp.
Nobel Resources is a Canadian resource company focused on identifying and developing prospective mineral projects. The Company states it has a team with a strong background of exploration success.
About ArcStone Financial Pulse
Stay informed with the latest market trends from ArcStone Securities and Investments Corp. Subscribe to our newsletter for more detailed reports and analysis.
Disclaimer and Forward-Looking Statements
The information contained herein is provided by ArcStone Securities and Investments Corp. (“ArcStone”) for informational purposes only. It is not, and under no circumstances should it be construed as, an offer to sell or a solicitation of an offer to buy any securities or other financial instruments in any jurisdiction.
Certain statements contained herein may constitute “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements are based on current expectations, estimates, and assumptions that involve known and unknown risks and uncertainties which may cause actual results or developments to differ materially from those expressed or implied. These statements often include words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “should,” “target,” or similar expressions. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Except as required by law, ArcStone undertakes no obligation to update or revise any forward-looking information.
This content is not intended as investment advice or a recommendation to buy or sell any security and does not take into account the investment objectives, financial situation, or needs of any individual. Investors should consult their own professional advisors before making any investment decisions.
ArcStone Securities and Investments Corp. is not a registered broker-dealer and does not provide investment advice or recommendations. All registrable activities in the United States are conducted through ArcStone Securities, LLC and Kingswood US, both FINRA-registered broker-dealers. In Canada, on a transaction-by-transaction basis, all registrable activities are conducted through a registered Exempt Market Dealer (EMD).
The issuer featured in this article (the “Company”) is a current or recent client of ArcStone or one of its affiliates. ArcStone and/or its affiliates have received or expect to receive cash and/or equity compensation for the provision of corporate advisory, investor relations, digital media, or capital markets consulting services to the Company. This relationship represents a potential conflict of interest, as ArcStone may be perceived to have an incentive to present the Company in a favorable light. The principals, officers, directors, employees, and related entities of ArcStone and its affiliates may, from time to time, own, buy, or sell securities or derivatives of the Company or its affiliates.
